Imidazo[1,2-<i>a</i>]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance-Reference-Cited by-同舟云学术

Imidazo[1,2-a]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance

Published:2023-02-13 Issue:4 Volume:66 Page:2804-2831
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Li Hui¹²,Zhang Sheng-Lie¹²,Jia Yan-Han³,Li Qian¹²,Feng Zi-Wen¹²,Zhang Shi-Duo¹²,Zheng Wei¹²,Zhou Ye-Ling¹²,Li Lin-Lin¹²,Liu Xue-Chun¹²,Chen Ya-Qiong³,Peng Hui³,You Qi-Dong¹²^ORCID,Xu Xiao-Li¹²^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines, and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China

2. Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China

3. Department of Operational Medicine, Tianjin Institute of Environmental & Operational Medicine, Tianjin 300050, China

Funder

State Key Laboratory of Natural Medicines

Qinglan Project of Jiangsu Province of China

China Pharmaceutical University

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Foundation Research Project of Jiangsu Province

Publisher

American Chemical Society (ACS)

Subject